Literature DB >> 24319644

Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.

Hiroshige Fujishiro1, Akiko Yamashita Imamura, Wen-Lang Lin, Hirotake Uchikado, Margery H Mark, Lawrence I Golbe, Katerina Markopoulou, Zbigniew K Wszolek, Dennis W Dickson.   

Abstract

The clinical features of the genetically determined forms of familial Parkinson's disease (PD) have been described in multiple reports, but there have been few comparative neuropathologic studies. Five familial PD cases, with mutations in SNCA, were matched for age, sex, and Alzheimer type pathology with sporadic PD cases. Immunohistochemistry for phospho-tau and α-synuclein was performed in 8 brain regions. The frequency of tau pathology and the morphologic features of α-synuclein pathology in familial PD were compared with sporadic PD using semi-quantitative methods. In familial PD, there were significantly more tau positive extra-perikaryal spheroid-like and thread-like lesions than in the sporadic PD. There was no significant difference in the amount of α-synuclein positive neuronal perikaryal pathology between familial PD and sporadic PD, but α-synuclein positive oligodendroglial and neuritic lesions were significantly greater in familial PD compared to sporadic PD. In the substantia nigra, familial PD had more marked neuronal loss and fewer residential neurons with Lewy bodies than the sporadic PD, suggesting a close relationship between the severity of neuronal loss and Lewy body formation. The results show a diversity of pathological features of genetically determined familial PD, and they draw attention to the possible role of tau protein in neurodegeneration. Moreover, the presence of oligodendroglial inclusions at the light and electron microscopic levels in familial PD suggests that PD and multiple system atrophy form a continuum of α-synuclein pathology.

Entities:  

Keywords:  Lewy bodies; Pathological features; SNCA mutations; familial Parkinson’s disease

Year:  2013        PMID: 24319644      PMCID: PMC3852566     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  33 in total

1.  Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Authors:  Hiroshige Fujishiro; Yoshio Tsuboi; Wen-Lang Lin; Hirotake Uchikado; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-04-30       Impact factor: 17.088

2.  Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.

Authors:  Akihide Mochizuki; Yasuko Komatsuzaki; Shin'ichi Shoji
Journal:  Acta Neuropathol       Date:  2002-06-27       Impact factor: 17.088

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.

Authors:  Keiji Yamaguchi; Elizabeth J Cochran; Jill R Murrell; Mihael H Polymeropoulos; Kathleen M Shannon; R Anthony Crowther; Michel Goedert; Bernardino Ghetti
Journal:  Acta Neuropathol       Date:  2005-06-25       Impact factor: 17.088

5.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

Review 6.  Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

Authors:  Dennis W Dickson; Heiko Braak; John E Duda; Charles Duyckaerts; Thomas Gasser; Glenda M Halliday; John Hardy; James B Leverenz; Kelly Del Tredici; Zbigniew K Wszolek; Irene Litvan
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

7.  Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Authors:  K Markopoulou; D W Dickson; R D McComb; Z K Wszolek; L Katechalidou; L Avery; M S Stansbury; B A Chase
Journal:  Acta Neuropathol       Date:  2008-04-04       Impact factor: 17.088

8.  G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome.

Authors:  Suzanne Lesage; Mathieu Anheim; Franck Letournel; Luc Bousset; Aurélie Honoré; Nelly Rozas; Laura Pieri; Karine Madiona; Alexandra Dürr; Ronald Melki; Christophe Verny; Alexis Brice
Journal:  Ann Neurol       Date:  2013-04       Impact factor: 10.422

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.

Authors:  D W Dickson; M L Schmidt; V M Lee; M L Zhao; S H Yen; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

View more
  12 in total

Review 1.  Autosomal dominant Parkinson's disease caused by SNCA duplications.

Authors:  Takuya Konno; Owen A Ross; Andreas Puschmann; Dennis W Dickson; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2015-09-03       Impact factor: 4.891

Review 2.  Neuropathology of Parkinson disease.

Authors:  Dennis W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2017-08-01       Impact factor: 4.891

3.  Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.

Authors:  Shunsuke Koga; Maiko Ono; Naruhiko Sahara; Makoto Higuchi; Dennis W Dickson
Journal:  Mov Disord       Date:  2017-04-25       Impact factor: 10.338

Review 4.  α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Authors:  Kaie Rosborough; Neha Patel; Lorraine V Kalia
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

Review 5.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

6.  Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson's disease.

Authors:  Faria Zafar; Ruksana Azhu Valappil; Sam Kim; Krisztina K Johansen; Anne Lynn S Chang; James W Tetrud; Peggy S Eis; Eli Hatchwell; J William Langston; Dennis W Dickson; Birgitt Schüle
Journal:  NPJ Parkinsons Dis       Date:  2018-06-15

Review 7.  Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges.

Authors:  Alain Ndayisaba; Marcos Herrera-Vaquero; Gregor K Wenning; Nadia Stefanova
Journal:  Clin Auton Res       Date:  2019-06-11       Impact factor: 4.435

8.  Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.

Authors:  Diego Perez-Rodriguez; Maria Kalyva; Melissa Leija-Salazar; Tammaryn Lashley; Maxime Tarabichi; Viorica Chelban; Steve Gentleman; Lucia Schottlaender; Hannah Franklin; George Vasmatzis; Henry Houlden; Anthony H V Schapira; Thomas T Warner; Janice L Holton; Zane Jaunmuktane; Christos Proukakis
Journal:  Acta Neuropathol Commun       Date:  2019-12-23       Impact factor: 7.801

9.  Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.

Authors:  Silke Nuber; Molly Rajsombath; Georgia Minakaki; Jürgen Winkler; Christian P Müller; Maria Ericsson; Barbara Caldarone; Ulf Dettmer; Dennis J Selkoe
Journal:  Neuron       Date:  2018-10-10       Impact factor: 17.173

Review 10.  Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.

Authors:  Kurt A Jellinger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.